New protease inhibitor TMC-114. Preliminary 24-week late breaker results of the phase II trial.
Berger
Daniel S
DS
D018791:CD4 Lymphocyte Count; D000069454:Darunavir; D015658:HIV Infections / Q000188:drug therapy*; D017320:HIV Protease Inhibitors / Q000627:therapeutic use*; D006801:Humans; D013449:Sulfonamides / Q000627:therapeutic use*; D019562:Viral Load
D017320:HIV Protease Inhibitors; D013449:Sulfonamides; D000069454:Darunavir